Justin Bowers
Stock Analyst at Deutsche Bank
(3.16)
# 984
Out of 4,667 analysts
57
Total ratings
39.39%
Success rate
5.39%
Average return
Main Sectors:
Stocks Rated by Justin Bowers
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WAT Waters | Maintains: Hold | $310 → $325 | $357.77 | -9.16% | 3 | Nov 4, 2024 | |
| IQV IQVIA Holdings | Maintains: Buy | $270 → $265 | $194.38 | +36.33% | 2 | Nov 1, 2024 | |
| FTRE Fortrea Holdings | Maintains: Hold | $28 → $23 | $19.15 | +20.10% | 3 | Aug 20, 2024 | |
| CON Concentra Group Holdings Parent | Initiates: Buy | $29 | $21.26 | +36.41% | 1 | Aug 19, 2024 | |
| AMED Amedisys | Downgrades: Hold | $101 | $90.00 | +12.22% | 11 | Jul 31, 2024 | |
| MEDP Medpace Holdings | Maintains: Hold | $395 → $336 | $326.09 | +3.04% | 2 | Jul 24, 2024 | |
| TXG 10x Genomics | Downgrades: Hold | $55 → $25 | $13.32 | +87.69% | 3 | Jul 10, 2024 | |
| RGEN Repligen | Upgrades: Buy | $180 → $155 | $138.90 | +11.59% | 2 | Jun 26, 2024 | |
| TMO Thermo Fisher | Maintains: Buy | $600 → $610 | $512.84 | +18.95% | 3 | Apr 25, 2024 | |
| TECH Bio-Techne | Maintains: Buy | $85 → $82 | $68.72 | +19.32% | 2 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $23 → $25 | $20.14 | +24.13% | 3 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $37 → $45 | $59.00 | -23.73% | 8 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $17 | $4.82 | +252.70% | 3 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $280 → $300 | $203.67 | +47.30% | 2 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $310 → $275 | $233.10 | +17.98% | 2 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $250 | $311.66 | -19.78% | 1 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $350 → $290 | $187.90 | +54.34% | 1 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $42 → $46 | $38.09 | +20.77% | 5 | May 10, 2021 |
Waters
Nov 4, 2024
Maintains: Hold
Price Target: $310 → $325
Current: $357.77
Upside: -9.16%
IQVIA Holdings
Nov 1, 2024
Maintains: Buy
Price Target: $270 → $265
Current: $194.38
Upside: +36.33%
Fortrea Holdings
Aug 20, 2024
Maintains: Hold
Price Target: $28 → $23
Current: $19.15
Upside: +20.10%
Concentra Group Holdings Parent
Aug 19, 2024
Initiates: Buy
Price Target: $29
Current: $21.26
Upside: +36.41%
Amedisys
Jul 31, 2024
Downgrades: Hold
Price Target: $101
Current: $90.00
Upside: +12.22%
Medpace Holdings
Jul 24, 2024
Maintains: Hold
Price Target: $395 → $336
Current: $326.09
Upside: +3.04%
10x Genomics
Jul 10, 2024
Downgrades: Hold
Price Target: $55 → $25
Current: $13.32
Upside: +87.69%
Repligen
Jun 26, 2024
Upgrades: Buy
Price Target: $180 → $155
Current: $138.90
Upside: +11.59%
Thermo Fisher
Apr 25, 2024
Maintains: Buy
Price Target: $600 → $610
Current: $512.84
Upside: +18.95%
Bio-Techne
Apr 18, 2024
Maintains: Buy
Price Target: $85 → $82
Current: $68.72
Upside: +19.32%
Apr 18, 2024
Maintains: Hold
Price Target: $23 → $25
Current: $20.14
Upside: +24.13%
Aug 15, 2023
Maintains: Hold
Price Target: $37 → $45
Current: $59.00
Upside: -23.73%
Aug 8, 2023
Maintains: Buy
Price Target: $23 → $17
Current: $4.82
Upside: +252.70%
Jul 14, 2023
Maintains: Buy
Price Target: $280 → $300
Current: $203.67
Upside: +47.30%
Apr 27, 2023
Maintains: Buy
Price Target: $310 → $275
Current: $233.10
Upside: +17.98%
Dec 14, 2022
Initiates: Hold
Price Target: $250
Current: $311.66
Upside: -19.78%
Jul 14, 2022
Maintains: Buy
Price Target: $350 → $290
Current: $187.90
Upside: +54.34%
May 10, 2021
Maintains: Buy
Price Target: $42 → $46
Current: $38.09
Upside: +20.77%